Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Gary Van Nest"'
Autor:
Meri K Tulic, Pota Christodoulopoulos, Pierre Olivier Fiset, Patrice Vaillancourt, Francois Lavigne, Jason D Marshall, Gary Van Nest, Joseph J Eiden, Qutayba Hamid
Publikováno v:
Allergology International, Vol 58, Iss 4, Pp 565-572 (2009)
Background: Allergen immunotherapy is effective in allergic individuals however efforts are being made to improve its safety, convenience, and efficacy. It has recently been demonstrated that allergen-linked immunostimulatory DNA (ISS) is effective i
Externí odkaz:
https://doaj.org/article/3a22af19e0414b69a01dd460b4e374d6
Autor:
Alivelu Irrinki, Nga Nguyen, Corinne Cayatte, A. Louise McCormick, Hong Jin, Christine Nelson, Lorraine Gemmell, Esteban Servat, Andrzej Citkowicz, Jennifer Woo, Gregory Duke, Janine Lu, Yi Liu, Zhaoti Wang, Gregory M. Hayes, Kirsten Schneider-Ohrum, Gary Van Nest
Publikováno v:
Journal of Virology. 87:11107-11120
Human cytomegalovirus (HCMV), a betaherpesvirus, can cause severe disease in immunosuppressed patients and following congenital infection. A vaccine that induces both humoral and cellular immunity may be required to prevent congenital infection. Dens
Publikováno v:
Expert Review of Vaccines. 6:747-759
Immunostimulatory DNA containing unmethylated CpG motifs is recognized by Toll-like receptor 9, resulting in the activation of innate immune responses that subsequently amplify the adaptive-immune response. Advances in the characterization of Toll-li
Autor:
Robyn McCall-Sani, Shelly A. McNeil, Simon Dobson, Dan Levitt, Bruce Smith, Gary Van Nest, Joanne M. Langley, Daniel Gennevois, Joseph Eiden, Scott A. Halperin
Publikováno v:
Vaccine. 24:20-26
Background Many individuals do not respond to a three-dose series of hepatitis B vaccine (HBV) and most do not achieve a protective antibody response until after dose 2 or 3. Methods Healthy, seronegative 18–28 year old adults were randomly assigne
Publikováno v:
Immunology. 117:38-46
Immunostimulatory sequences (ISS) that contain CpG motifs have been demonstrated to exert antipathogen and antitumour immunity in animal models through several mechanisms, including the activation of natural killer (NK) cells to secrete interferon-ga
Autor:
Jeffrey D. Lifson, Rudolf P. Bohm, Jason Marshall, Jessica Kenney, Gary Van Nest, Jason Dufour, Melissa Pope, Agegnehu Gettie, Jennifer Jones, Natalia Teleshova
Publikováno v:
The Journal of Immunology. 173:1647-1657
There are two principle subsets of dendritic cells (DCs); CD11c+CD123− myeloid DCs (MDCs) and CD11c−CD123+ plasmacytoid DCs (PDCs). DC activation via TNF-TNFRs (e.g., CD40L) and TLRs (e.g., immunostimulatory oligodeoxyribonucleotides (ISS-ODNs))
Publikováno v:
Journal of Allergy and Clinical Immunology. 113:1144-1151
Background In animal models administration of immunostimulatory DNA sequences preferentially elicits T H 1-dominated (type 1-dominated) immunity and can inhibit developing or ongoing T H 2 (type 2) responses. Objective Our objective was to investigat
Autor:
Christi Abbate, Karen L. Fearon, Tracy dela Cruz, Debbie Higgins, Gary Van Nest, David Passmore, Jason Marshall, Stephen Tuck, Gary Ott, Priscilla Yee, Glen Teshima
Publikováno v:
Cellular Immunology. 229:93-105
The immunostimulatory effects of bacterial DNA on mammalian cells have been localized to unmethylated CpG motifs, and synthetic CpG-containing oligodeoxynucleotides that mimic these effects are known as immunostimulatory sequences (ISS). We have foun
Autor:
Gary Van Nest, Darrell L. Peterson, David R. Milich, Roderick Tang, Joyce E. Jones, Michael P. McCarthy, Heather Lawlor, Jasmine Kaur, David C. Whitacre, Jeanne H. Schickli, Cory J. Peters
Publikováno v:
The Journal of clinical investigation. 125(4)
Respiratory syncytial virus (RSV) is the most common cause of serious viral bronchiolitis in infants, young children, and the elderly. Currently, there is not an FDA-approved vaccine available for RSV, though the mAb palivizumab is licensed to reduce
Autor:
David A. Schwartz, Joseph Eiden, Stephen Tuck, Anne Kagey-Sobotka, Gary Van Nest, Peter S. Creticos, Kenji Takabayashi, H Tighe, Lawrence M. Lichtenstein, Hans L. Spiegelberg, Eyal Raz
Publikováno v:
Journal of Allergy and Clinical Immunology. 106:124-134
Background: Allergen immunotherapy is inconvenient and associated with the risk of anaphylaxis. Efforts to improve the safety of immunotherapy by means of chemical modification of allergens have not been successful because it greatly reduced their an